Cyclosporine A-induced contractions and prostacyclin release are maintained by extracellular calcium in rat aortic rings: Role of protein kinase C

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 56, Issue 2, 1997, Pages 151-156

  Oriji, G K ^a   Keiser, H R ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 1 (5 ISOQUINOLINESULFONYL)PIPERAZINE; CYCLOSPORIN A; DILTIAZEM; IMMUNOSUPPRESSIVE AGENT; PROSTACYCLIN; PROTEIN KINASE C; STAUROSPORINE; THAPSIGARGIN;

ANIMAL TISSUE; AORTA; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; EXTRACELLULAR CALCIUM; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR RING; VASOCONSTRICTION;

ANIMALIA;

EID: 0031049928     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(97)90512-3     Document Type: Article

References (39)

1. Zoja C., Furci L., Ghilardi G., Zilio P., Benigni A., Remuzzi G. Cyclosporine-induced endothelial cell injury. Lab Invest 1986; 55: 455-462.
2. Lamb F. S., Webb R. C. Cyclosporine augments reactivity of isolated blood vessels. Life Sciences 1987; 40: 2571-2578.
3. Rego A., Vargas R., Wroblewska B., Foegh M. L., Ramwell P. W. Attenuation of vascular relaxation and cyclic GMP responses in cyclosporine A. J Pharm Exp Ther 1990; 252: 165-170.
4. Bossaller C., Förstermann U., Hertell R., Olbricht C., Reschke V., Fleck E. Cyclosporin A inhibits endothelin-dependent vasodilatation and vascular prostacyclin production. Eur J Pharmacol 1989; 165: 165-169.
5. Golub M. S., Lustig S., Berger M. E., Lee D. B. N. Altered vascular responses in cyclosporine-treated rats. Transplantation 1989; 48: 116-118.
6. Auch-Schwelk W., Bossaller C., Götze S., Thelen J., Fleck E. Endothelial and vascular smooth muscle function after chronic treatment with cyclosporine A. J Cardiovasc Pharmacol 1993; 21: 435-440.
7. Xue H., Bukowski R. D., McCarron D. A., Bennet W. M. Introduction of contraction in isolated rat aorta by cyclosporin. Transplantation 1987; 43: 715-718.
8. Habib J. B., Bossaller C., Wells S., Williams F., Morriset J. D., Henry P. D. Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with the calcium-blocker PN200110. Circ Res 1986; 58: 305-309.
9. Addel-Latiff A. A. Calcium-mobilizing receptors, polyphosphoinositides, and the generation of second messengers. Pharmacol Rev 1986; 38: 227-265.
10. Rasmussen H., Takuwa Y., Park S. Protein Kinase C in the regulation of smooth muscle contraction. FASEB J 1987; 1: 177-185.
11. Haller H., Spies K., Lindschau C., Quass P., Distler A. The effect of cyclosporine on calcium, protein kinase C, and sodium-proton exchange in platelets. Transplantation 1994; May 27; 57(10): 1516-1520.
12. 2+ and protein kinase C. Biochem J 1993; 290(Pt 1): 135-138.
13. Peach M. J. Molecular actions of angiotensin. Biochem Pharmacol 30; 1981: 2745-2751.
14. Eulalia B., Campbell A. K., Rapoport R. M. Protein Kinase C activity in blood vessels from normotensive and spontaneously hypertensive rats. Eur J Pharm 1992; 227: 343-348.
15. Campbell W. B. Lipid-derived autacoids: eicosanoids and platelet-activating factor. In: Gilman A. G., Rall T. W., Nies A. S., Taylor P. eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York: Pergamon Press, 1990: 600.
16. McNally P. G., Heagerty A. M., Walls J., Feehally J. Phosphoinositide hydrolysis is not enhanced by cyclosporin. Nephron 1991; 59: 512-514.
17. Meyer-Lehnert H., Schrier R. W. Potential mechanism of cyclosporin A-induced vascular smooth muscle contraction. Hypertension 1989; 13: 252-260.
18. 2+ fluxes in isolated hepatocytes. J Biol Chem 1985; 260: 13613-13618.
19. Meyer-Lehnert H., Schrier R. W. Cyclosporine A enhances vasopressin-induced calcium mobilization and contraction in mesangial cells. Kidney Int 1988; 34: 89-97.
20. Tropschug M., Hofmann R. FK 506 and protein kinase C. Nature 1991; 351: 195.
21. Goebl M. G. The peptidyl-prolyl isomerase FK506-binding protein is most likely the 12 kD endogenous inhibitor 2 of protein kinase C. Cell 1991; 64: 1051.
22. Neary J. R., Norenberg L. O. B., Norenberg M. D. Protein kinase C in primary astrocyte cultures: cytoplasmic localization and translocation by a phorbol ester. J Neurochem 1988; 50: 1179-1184.
23. Nishizuka Y. Turnover of inositol phospholipids and signal transduction. Science 1984; 225: 1365-1370.
24. Sano K., Takai Y., Yamanishi J., Nishizuka Y. A role of calcium-activated phospholipid-dependent protein kinase in human platelet activation. Comparison of thrombin and collagen actions. J Biol Chem 1983; 258: 2010-2013.
25. Bocckino S. B., Blackmore P. F., Exton J. H. Stimulation of 1,2-diacylglycerol accumulation in hepatocytes by vasopressin, epinephrine, and angiotensin II. J Biol Chem 1985; 260: 14201-14207.
26. Rothhut B., Russo-Marie F., Wood J., DiRosa M., Flower R. J. Further characterization of the glucocorticoid-induced antiphospholipase protein renocortin. Biochem Biophys Res Commun 1983; 117: 878-884.
27. Hirata F. The regulation of lipomodulin, a phospholipase inhibitory protein, in rabbit neutrophils by phosphorylation. J Biol Chem 1981; 256: 7730-7733.
28. Hirata F., Matsuda K., Notsu Y., Hattori T., delCarmine R. Phosphorylation at a tyrosine residue of lipomodulin in mitogen-stimulated murine thymocytes. Proc Natl Acad Sci USA 1984; 81: 4717-4721.
29. Touqui L., Rothhut B., Shaw A. M., Fradin A., Vargaftig B. B., Russo-Marie F. Platelet activation - a role for a 40 K antiphospholipase A2 protein indistinguishable from lipocortin. Nature 1986; 1321: 177-180.
30. Debbaghi A., Hidi R., Vargaftig B. B., Touqui L. Inhibition of phospholipase A2 activity in guinea pig eosinophilis by human recombinant IL-1 beta. J Immunol 1992; 149: 1374-80.
31. Gao G., Serrero G. Phospholipase A2 is a differentiation dependent enzymatic activity for adipogenic cell line and adipocyte precursors in primary culture. J Biol Chem 1990; 265: 2431-2434.
32. Shoyab M., Todaro G. J. Specific high affinity cell membrane receptors for biologically active phorbol and ingenal esters. Nature 1980; 288: 451-455.
33. Busija D. W., Leffler C. W. Effects of phorbol esters on pial arteriolar diameter and brain production of prostanoids in piglets. Circ Res 1991; 69: 1253-1258.
34. Hidaka H., Inagaki M., Kawamoto S., Sasaki Y. Isoquinoline sulfonamides, novel potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 1984; 25: 5036-5041.
35. Busija D. W., Heistad D. D. Factors involved in physiological regulation of cerebral blood flow. Rev Physiol Biochem Pharmacol 1984; 101: 161-211.
36. Busija D. W., Wagerle L. C., Pourcyrous M., Leffler C. W. Acetylcholine dramatically increases prostanoid synthesis in piglet parietal cortex. Brain Res 1988; 439: 122-126.
37. Busija D. W., Leffler C. W. Dilator effects of amino acid neurotransmitters on piglet pial arterioles. Am J Physiol 1989; 257 (Heart Circ. Physiol. 26): H1200-H1203.
38. Pfeilschifter J., Ruegg U. T. Cyclosporine A augments angiotensin II-stimulated rise in intracellular free calcium in vascular smooth muscle cells. Biochem J 1987; 248: 883-887.
39. Kraft A. S., Anderson W. B. Characterization of cytosolic calcium-activated phospholipid-dependent protein kinase activity in embroynal carcinoma cells. J Biol Chem 1983; 258: 9178-9183.